Elekta International
Elekta Australia
Elekta Canada
Elekta China
Elekta Hong Kong
Elekta India
Elekta Japan
Elekta New Zealand
Elekta Singapore
Elekta United States
ELEKTA'S OPPONENT IN PATENTDISPUTE FILES PETITION TO U.S SUPREME COURT
As previously announced,on September 22, 2003, the United States Court of Appeals for theFederal Circuit vacated the $24 million September 10, 2002judgment entered against Elekta after a trial in the UnitedStates District Court for the Southern District of California.The appeals court’s decision absolved Elekta of allliability.
On October 30, 2003, the appealscourt announced its decision to deny a petition from MedicalInstrumentation and Diagnostics Corporation (Midco), Elekta'sopponent in the patent dispute, to reconsider its ruling issuedon September 22, 2003.
On Monday, January 26, 2004, Midcofiled a petition for a writ of certiorari with the United StatesSupreme Court, requesting review of the Federal Circuit'sjudgment.
A petition for a writ ofcertiorari is a petition requesting the right to file an appeal.Grant of this remedy is unusual. In the context of patent cases,the Supreme Court typically grants certiorari in only a very fewcases a year.
For further information, pleasecontact:
International: Peter Ejemyr, Group VP CorporateCommunications, Elekta AB (publ),
Phone: +46 733 611 000, e-mail: peter.ejemyr@elekta.com
United States: Lars Jonsteg, VPInvestor Relations North America, Elekta, USA
Phone: +1 770-670-2419, e-mail: lars.jonsteg@elekta.com
Elekta is a world-leading supplierof advanced and innovative radiation oncology and neurosurgerysolutions and services for precise treatment of cancer and braindisorders. Elekta's solutions are clinically effective, costefficient and gentle to the patient.
For additional information aboutElekta, please visit www.elekta.com
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
 |  |